Month: March 2021

Mar 09 2021

Uncategorized

An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data

by Clinical Editor

No Comments

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187–92. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological …

Mar 09 2021

Uncategorized

Schizophrenia and Relationships

by Clinical Editor

No Comments

One of the more challenging things about schizophrenia is trouble forming close relationships with family, friends, and romantic partners. But studies show that strong social ties that offer emotional …

Mar 09 2021

Uncategorized

Anti-hyperlipidemia drug improves brain connectivity in mouse models of schizophrenia

by Clinical Editor

No Comments

New therapies that improve connectivity and circuitry in the brain of people with schizophrenia could result from the discovery by a RIKEN-led team of a potential new target for drugs...

Mar 08 2021

Uncategorized

How do established developmental risk-factors for schizophrenia change the way the brain develops?

by Clinical Editor

No Comments

The recognition that schizophrenia is a disorder of neurodevelopment is widely accepted. The original hypothesis was coined more than 30 years ago and the wealth of supportive epidemiologically data …

Mar 08 2021

Uncategorized

An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data

by Clinical Editor

No Comments

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187–92. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological …

Mar 08 2021

Uncategorized

Researchers use powerful X-rays to analyze brain tissues of schizophrenia patients

by Clinical Editor

No Comments

Schizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person’s thoughts, feelings and behavior.

Mar 08 2021

Uncategorized

Anti-hyperlipidemia drug improves brain connectivity in mouse models of schizophrenia

by Clinical Editor

No Comments

New therapies that improve connectivity and circuitry in the brain of people with schizophrenia could result from the discovery by a RIKEN-led team of a potential new target for drugs...

Mar 08 2021

Uncategorized

Global Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR of 2.7% during the forecast period – by PMI

by Clinical Editor

No Comments

The global schizophrenia drug market accounted for US$ 7.5 Bn in 2020 and is estimated to be US$ 9.8 Bn by 2030 and is anticipated to register a CAGR of...

Mar 07 2021

Uncategorized

Anti-hyperlipidemia drug improves brain connectivity in mouse models of schizophrenia

by Clinical Editor

No Comments

New therapies that improve connectivity and circuitry in the brain of people with schizophrenia could result from the discovery by a RIKEN-led team of a potential new target for drugs...

Mar 07 2021

Uncategorized

CVD risk factors tied to cognitive impairment in schizophrenia

by Clinical Editor

No Comments

(HealthDay)—Cardiovascular risk factors are associated with cognitive impairment among individuals with schizophrenia, according to a review and meta-analysis published online March 3 in JAMA …